ArticleJournal of virology2026
ATG9A is an essential host factor for parechovirus RNA replication.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Parechoviruses (PeVs) are single-stranded, positive-sense RNA viruses in the IMPORTANCE: Parechovirus (PeV) is a widespread but understudied human pathogen capable of causing severe neurologic disease and sepsis in neonates and infants. Through a CRISPR-based screen, we identified key host factors required for PeV-A3 infection and uncovered a novel, critical role of ATG9A in viral RNA replication that is independent of canonical autophagy. These findings provide new insight into the molecular pathogenesis of the virus and establish a foundation for future antiviral therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.